|
|
|
Volumn 5, Issue 3, 2002, Pages 209-212
|
|
Clinical Gene Therapy - First International Conference 24-26 January 2002, Groningen, the Netherlands
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADENOVIRUS VECTOR;
ANTINEOPLASTIC AGENT;
ARGINYLGLYCYLASPARTIC ACID;
BLOOD CLOTTING FACTOR 8;
CYTOSINE DEAMINASE;
DYSTROPHIN;
EPIDERMAL GROWTH FACTOR;
GANCICLOVIR;
GROWTH HORMONE;
HUMAN B DOMAIN DELETED BLOOD CLOTTING FACTOR 8;
LIGAND;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;
MONOCLONAL ANTIBODY CC49;
NEOMYCIN;
PLACEBO;
PROTEIN E6;
PROTEIN E7;
RETROVIRUS VECTOR;
SDZ GLI 328;
THYMIDINE KINASE;
UNCLASSIFIED DRUG;
UTROPHIN;
VASCULOTROPIN;
VIRUS RECEPTOR;
VIRUS VECTOR;
ANGIOGENESIS;
BLOOD VESSEL PERMEABILITY;
CANCER;
CANCER CELL;
CANCER IMMUNOTHERAPY;
CANCER RADIOTHERAPY;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CYSTIC FIBROSIS;
DISEASE MODEL;
DISEASE SEVERITY;
DRUG BIOAVAILABILITY;
DRUG EFFICACY;
DRUG SAFETY;
DUCHENNE MUSCULAR DYSTROPHY;
EDEMA;
FEVER;
GENE DELIVERY SYSTEM;
GENE THERAPY;
GENETIC DISORDER;
GLIOBLASTOMA;
HEART MUSCLE ISCHEMIA;
HEMANGIOMA;
HEMOPHILIA;
HEMOPHILIA A;
HUMAN;
HYPOTENSION;
LIMB ISCHEMIA;
LIVER DYSFUNCTION;
NONHUMAN;
OVARY CANCER;
SIDE EFFECT;
SUICIDE GENE THERAPY;
SYSTEMIC THERAPY;
VACCINATION;
|
|
EID: 0141560772
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (4)
|
|
References (0)
|
